Basics Axogen, Inc. Common Stock AxoGen Inc is a medical technology company dedicated to peripheral nerve repair. It provide products and education to improve surgical treatment algorithms for peripheral nerve injuries. IPO Date: January 1, 1987 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $735.28M Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 2.46% Avg Daily Range (30 D): $0.32 | 2.24% Avg Daily Range (90 D): $0.31 | 2.44% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): 1.57M Avg Daily Volume (90 D): .94M Trade Size Avg Trade Size (Sh.): 92 Avg Trade Size (Sh.) (30 D): 88 Avg Trade Size (Sh.) (90 D): 76 Institutional Trades Total Inst.Trades: 1,172 Avg Inst. Trade: $1.3M Avg Inst. Trade (30 D): $1.97M Avg Inst. Trade (90 D): $1.52M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.32M Avg Closing Trade (30 D): $1.94M Avg Closing Trade (90 D): $1.46M Avg Closing Volume: 80.3K     News Jul 30, 2025 @ 5:00 PM Global Amniotic Membrane Market Poised for Extraor... Source: Delveinsight Feb 11, 2025 @ 9:58 PM Axogen, Inc. to report 2024 fourth quarter and ful... Source: N/A Oct 7, 2024 @ 7:45 PM Bruker Stock Gains From Its Latest Acquisition of ... Source: Zacks Oct 3, 2024 @ 4:50 PM Here's Why You Should Retain BRKR Stock in Your Po... Source: Zacks Sep 24, 2024 @ 4:23 PM First September Gains in 5 Years? Buy 3 Breakout S... Source: Zacks Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.1 $.01 $-.08 Diluted EPS $-.1 $.01 $-.08 Revenue $ 203.27M $ 56.66M $ 48.56M Gross Profit $ 150.96M $ 42.02M $ 34.93M Net Income / Loss $ -4.66M $ .58M $ -3.83M Operating Income / Loss $ 1.71M $ 1.67M $ -1.66M Cost of Revenue $ 52.31M $ 14.64M $ 13.63M Net Cash Flow $ .85M $ 1.94M $ -9.46M PE Ratio